Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Breast Cancer Research and Treatment|May 9, 2021
Leptomeningeal Metastasis in ER + HER2- Advanced Breast Cancer Patients: A Review of the Cases in a Single Institute Over a 15-year PeriodJunichiro Watanabe, Koichi Mitsuya, Shogo Nakamoto, et al.
Scientific Reports|April 29, 2024
Absolute lymphocyte count and neutrophil-to-lymphocyte ratio as predictors of CDK 4/6 inhibitor efficacy in advanced breast cancerShogo Nakamoto, Tadahiko Shien, Takayuki Iwamoto, et al.
International Cancer Conference Journal|October 14, 2024
Radiation hepatitis after postmastectomy radiation therapy for early breast cancer: difficult to differentiate from drug-induced liver injury caused by abemaciclibShogo Nakamoto, Takahiro Waki, Asuka Mimata, et al.
Chinese Clinical Oncology|September 11, 2024
Primary angiosarcoma of the breast: a literature reviewYidan Zhu, Shogo Nakamoto, Takahiro Tsukioki, et al.
Breast Cancer (Tokyo, Japan)|February 12, 2025
Repeated sentinel lymph node biopsy for local recurrence after breast-conserving surgeryYuka Matsubara, Nobuyasu Suganuma, Shogo Nakamoto, et al.
European Journal of Radiology Open|October 24, 2019
Imaging features of breast cancer with marked hemosiderin deposition: A case reportTaiyo L Harada, Kazuaki Nakashima, Takayoshi Uematsu, et al.
European Radiology|February 17, 2020
Is the presence of edema and necrosis on T2WI pretreatment breast MRI the key to predict pCR of triple negative breast cancer?Taiyo L Harada, Takayoshi Uematsu, Kazuaki Nakashima, et al.
Clinical and Experimental Medicine|October 31, 2023
Systemic immunity markers are associated with clinical outcomes of atezolizumab treatment in patients with triple-negative advanced breast cancer: a retrospective multicenter observational studyShogo Nakamoto, Tadahiko Shien, Mitsuya Itoh, et al.
Acta Medica Okayama|February 29, 2024
Ectopic Breast Cancer Arising within an Axillary Lymph NodeKei Toshima, Tadahiko Shien, Midori Filiz Nishimura, et al.
Breast Cancer (Tokyo, Japan)|May 23, 2026
Real-world uptake of gBRCA testing as a companion diagnostic for olaparib in patients with high-risk HER2-negative early breast cancer in Japan: a cross-sectional multicenter study (BRCAwareness)Tomoe Taji, Yukari Uemura, Yuri Kimura, et al.
Pageof 3